Noubar Afeyan tells the STAT Summit that political moves to replace facts with opinions won't stop with mRNA vaccines. "It’s ...

Moderna, Inc. remains under pressure in 2025, despite recent next-gen COVID vaccine approval & cancer vaccine trial. Learn ...

Over the last year, Noubar Afeyan has watched Cambridge-based Moderna go from perhaps the world’s most celebrated company ...

CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its ...

Moderna (MRNA), with its widely used COVID-19 vaccine, rose to prominence during the global pandemic. The stock soared an eye ...

Then, demand for its COVID-19 vaccine started to diminish. As hospitals resumed normal operations and anti-vaccine sentiment ...

Discover whether Moderna or BioNTech offers better long-term investment potential as both pivot from COVID-19 to innovative ...

To tailor cancer therapies to individual patients, Moderna, BioNTech and other companies are rethinking how they optimize ...

Visitors should bring their photo IDs and insurance cards. Accepted payments include Medicare, Medicaid, insurance, cash and ...

It’s that time of year when the leaves are turning golden, there’s a chill in the air and the threat of respiratory viruses ...

As the U.S. pulls the funding rug out from under African countries fighting infectious diseases, it is more necessary than ...

Over the past five years, 800 million people worldwide have been infected with COVID-19. The death toll has reached 7 million. Fatalities continue to occur even now. COVID-19 is now trending toward ...